Immunotech Laboratories Appoints New Chief

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Company's Growth and International Expansion Plan

Immunotech Laboratories, Inc. (PL) (USOTC:IMMB)
Intraday Stock Chart

Today : Thursday 7 February 2013

Click Here for more Immunotech Laboratories, Inc. (PL) Charts.
PASADENA, Calif., Feb. 7, 2013 /PRNewswire/ --

Immunotech Laboratories, Inc. (PINKSHEETS : IMMB )

Immunotech Laboratories, Inc., today announced the appointment of Mr. Valentin Dimitrov to the company Board of Directors as Chief Financial Advisor effective immediately.

Mr. Dimitrov (48) has an impressive professional history in the International Pharmaceutical World along with an impressive background in the formation and management of International Corporations, including the founding member and supervisory Board Chairman of the International Orthodox Bank – (present "Investbank" JSC).

Immunotech Director Bo Linton, further commented Mr. Dimitrov has an extensive knowledge of the Immunotech "IPF" patented technology and has worked alongside the company for several years, assisting with International awareness and potential Clinical Trial progression for the company's Immunotherapy Treatments.Immunotech President Harry Zhabilov commented, "We are very pleased to announce the appointment of Valentin to the Board of Directors and feel he will be a valuable member of our team, and significantly help accelerate the progression of the company towards FDA approval for the 'IPF' technology."

The appointment of Mr. Dimitrov to Immunotech's Board of Directors helps with the potential goal of upgrading the company to the NASDAQ exchange, where a minimum of 5 Board Members are required.

About Valentin Lordanov Dimitrov


EDUCATION:

Kliment Ohridski University

Master's degree - Social Pedagogics



Kiev State University, Ukraine

Bachelor of International Diplomatic Relations



SPECIALIZATIONS:

1995:

University of National and World Economy – Sofia - Finances



1999:

Chemical-technological University - Sofia - Organic chemistry



LANGUAGES:

English - Fluent , Russian - fluent , German – spoken


PROFESSIONAL BACKGROUND:

2007-Current:

"Vital-Fe" LTD – Distribution of bio-technology and pharmaceutical products – Director



2003-Present

"Bulgarian Association of Chemical and Fertilizer Industry" – Chairman



2002-2003

"Chimco Vienna" GmbH – Distributor of chemical and pharmaceutical products – Director



1999-2002

"CHIMCO" JSC, Vratza - Chemical production plant - Chairman of the Board of Directors



1992-1998

"Prima Gas" JSC – supply of natural gas – Director



1995-1996

"International Orthodox Bank" – (present "Investbank" JSC), Founder and member of the Supervisory Board



1994-1995

"Private Agricultural and Investment Bank" – Member of the Supervisory Board



1990-1991

"Pharmachem" JSC – pharmaceutical and chemical industry – Director of Department

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 17

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 55

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
PBM Transparency Rule: Game Changer for 136M Americans

Updated Category News Views 23

Turning the Tide on Pharmacy Costs The world of pharmacy benefits is getting a long-overdue shake-up, courtesy of a new rule mandating transparency from the pharmacy benefit managers (PBMs). This ain't your everyday administrative tweak—it's a seismic shift for the 136 million Americans tied into employer-sponsored health plans. Thanks to the U.S. Department of Labor...

Continue Reading
Yale's $10M Inflammation Initiative: Future Health Impact

Updated Category News Views 0

Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...

Continue Reading
TIOmarkets App Unveils Enhanced Trading Features

Updated Category News Views 32

Trading on the Go Takes a Leap Forward Pretty slick development from TIOmarkets, if I do say so myself. They've rolled out a major expansion of their mobile trading app, now packing some hefty features like Depth of Market and more granular order controls right from those little devices in our pockets. Quite the leap if you're one of those folks who can't keep your eyes...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 217

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Equitable Bank Bumps Rates Amid Market Shuffle

Updated Category News Views 57

Equitable Bank Dials Up Its Prime Rate Equitable Bank's taken a step that every borrower and investor out there can't ignore: they've hiked their prime lending rate by 25 basis points, pushing it up to 4.70% from 4.45%. Now, any old-timer in the trading arena knows that when banks shift their rates, it's not just numbers on paper—it ripples across the landscape, from...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 81

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era

Updated Category News Views 0

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Continue Reading
Quanta Services Reports Record Q3 2026 Earnings

Updated Category News Views 51

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Continue Reading

Top 5 Most Recently Viewed Articles

BullFrog AI's Direct Offering Could Elevate Growth Potential

Updated Category News Views 160

Bullfrog AI's Financial Moves to Propel Future Growth BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) is setting the stage for substantial growth with its latest financial initiatives. WallachBeth Capital announced that the company has entered into a definitive agreement for the sale of approximately 1,565,000 shares of common stock through a registered direct offering....

Continue Reading
Aclarion Strengthens Market Position with New UK Director

Updated Category News Views 138

New Leadership in the UK Market Aclarion, Inc. is excited to announce the appointment of Dan Isherwood as the new UK Commercial Director. This strategic hire marks a significant milestone for the company, enhancing its capacity to penetrate the UK healthcare market effectively. With a robust background in HealthTech, Isherwood is poised to help drive the utilization of...

Continue Reading
Navigating Travel Insurance Amidst Potential Government Shutdowns

Updated Category News Views 98

Navigating Travel Insurance Amidst Potential Government Shutdowns As uncertainties loom regarding potential government shutdowns, travelers find themselves questioning how these events might disrupt their plans. A looming government shutdown often leads to numerous challenges, including staffing shortages at key agencies such as the FAA and TSA. These essential services,...

Continue Reading
Immuthera's Advisory Board: Pioneering New Frontiers in Diabetes Care

Updated Category News Views 146

Immuthera's Scientific Advisory Board: Innovation at the Forefront Immuthera, a leading name in the field of cell therapies, is thrilled to introduce its newly assembled Scientific Advisory Board. This esteemed group includes renowned experts like Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman. Their collective expertise will drive innovative solutions in...

Continue Reading
Astroport and Orbit Fab Partner to Advance Lunar Exploration

Updated Category News Views 128

Astroport and Orbit Fab Team Up for Lunar Exploration Astroport Space Technologies, Inc., a leader in advanced space exploration solutions, and Orbit Fab, Inc., renowned for in-space refueling and resource utilization, have announced an exciting partnership aimed at accelerating lunar infrastructure development. This collaboration marks a pivotal moment in the quest for...

Continue Reading